Top Markets
#1 Black Phoenix Black Phoenix +21,324.94%
#2 Nesa Nesa +680.44%
#3 Ontology Gas Ontology Gas +77.37%
#4 Kinesis Silver Kinesis Silver +53.96%
#5 Biconomy Biconomy +30.85%
#6 QuantixAI QuantixAI +23.11%
#7 EXOD EXOD +22.78%
#8 SAFEcoin SAFEcoin +19.07%
#9 BNB Attestation Service BNB Attestation Service +18.39%
#10 Magma Finance Magma Finance +17.20%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Classificação em ações #19057
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Preço da ação
$1.27
Valor de mercado
$176.31M
Variação (1 dia)
5.57%
Variação (1 ano)
29.36%
País
TW
Negociar Medigen Biotechnology Corp. (3176)

Categoria

Healthcare
Receita da Medigen Biotechnology Corp. (3176)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Medigen Biotechnology Corp., a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Medigen Biotechnology Corp. de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH